Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T14:08:30.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T15:47:23.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov software revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T15:35:21.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site’s displayed revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T15:35:35.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The history now records a new system revision: v3.7.0. The previous revision, v3.6.6, is removed from the history.
    Difference
    0.1%
    Check dated 2026-09-19T19:26:17.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The record history now shows the latest revision as v3.6.6, replacing the prior v3.6.5 entry. This indicates a new version has been saved in the study's history.
    Difference
    0.1%
    Check dated 2026-08-29T18:41:30.000Z thumbnail image

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.